, Semi-Supervised Methods to Predict Patient Survival from Gene Expression Data, PLoS Biology, vol.25, issue.4, p.108, 2004.
DOI : 10.1371/journal.pbio.0020108.sd018
URL : http://doi.org/10.1371/journal.pbio.0020108
, Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies, Blood, vol.107, issue.7, pp.2633-2638, 2006.
DOI : 10.1182/blood-2005-10-4084
, Controlling the False Discovery Rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society. Series B, vol.57, pp.289-300, 1995.
, The control of the false discovery rate in multiple testing under dependency, The Annals of Statistics, vol.29, pp.1165-1188, 2001.
, The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition, Blood, vol.111, issue.3, pp.1603-1609, 2008.
DOI : 10.1182/blood-2007-06-097774
, Robust Likelihood-Based Survival Modeling with Microarray Data, Journal of Statistical Software, vol.29, issue.1, pp.1-16, 2009.
DOI : 10.18637/jss.v029.i01
URL : http://doi.org/10.18637/jss.v029.i01
, Practical Nonparametric Statistics, p.156, 1999.
, The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas A 4-Gene Signature Associated with Clinical Outcome in High-Grade Gliomas, PLoS ONE Clinical Cancer Research, vol.5, issue.17, pp.317-327, 2010.
, Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du My??lome, Journal of Clinical Oncology, vol.26, issue.29, pp.4798-4805, 2008.
DOI : 10.1200/JCO.2007.13.8545
, and the Clinical Response of Gliomas to Alkylating Agents, New England Journal of Medicine, vol.343, issue.19, pp.1350-1354, 2000.
DOI : 10.1056/NEJM200011093431901
, Concordance among Gene-Expression???Based Predictors for Breast Cancer, New England Journal of Medicine, vol.355, issue.6, pp.560-569, 2006.
DOI : 10.1056/NEJMoa052933
, Stromal gene expression predicts clinical outcome in breast cancer, Nature Medicine, vol.25, issue.5, pp.518-527, 2008.
DOI : 10.1038/nm1764
, Statistical Methods, Experimental Design, and Scientific Inference., Biometrics, vol.47, issue.3, p.84, 1990.
DOI : 10.2307/2532685
, Gene Expression Profiling of Gliomas Strongly Predicts Survival Bioconductor: open software development for computational biology and bioinformatics, Cancer Research Genome Biol Cancer Research, vol.64, issue.69, pp.6503-6510, 2004.
, International Staging System for Multiple Myeloma, Journal of Clinical Oncology, vol.23, issue.15, pp.3412-3420, 2005.
DOI : 10.1200/JCO.2005.04.242
, A refined molecular taxonomy of breast cancer, Oncogene, vol.10, issue.9, pp.1196-1206, 2012.
DOI : 10.1038/nature09515
URL : https://hal.archives-ouvertes.fr/inserm-00611752
, Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma, Haematologica, vol.96, issue.1, pp.87-95, 2010.
DOI : 10.3324/haematol.2010.030296
, Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma, Blood, vol.113, issue.18, pp.4331-4340, 2009.
DOI : 10.1182/blood-2008-09-178350
URL : https://hal.archives-ouvertes.fr/inserm-00368414
, On the exact distribution of maximally selected rank statistics, Computational Statistics & Data Analysis, vol.43, issue.2, pp.121-137, 2003.
DOI : 10.1016/S0167-9473(02)00225-6
, Adjusting batch effects in microarray expression data using empirical Bayes methods, Biostatistics, vol.8, issue.1, pp.118-127, 2007.
DOI : 10.1093/biostatistics/kxj037
, Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization, BMC Cancer, vol.335, issue.1, p.143, 2011.
DOI : 10.1056/NEJM199610033351408
, Microarray Based Diagnosis Profits from Better Documentation of Gene Expression Signatures, PLoS Computational Biology, vol.19, issue.2, p.22, 2008.
DOI : 10.1371/journal.pcbi.0040022.sg008
, A gene expression signature for high-risk multiple myeloma, Leukemia, 2012.
, GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes, BMC medical informatics and decision making, p.38, 2010.
, Unsupervised Analysis of Transcriptomic Profiles Reveals Six Glioma Subtypes, Cancer Research, vol.69, issue.5, pp.2091-2099, 2009.
DOI : 10.1158/0008-5472.CAN-08-2100
, The 2007 WHO Classification of Tumours of the Central Nervous System, Acta Neuropathologica, vol.64, issue.2, pp.97-109, 2007.
DOI : 10.1007/s00401-007-0243-4
, The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models, Nat Biotech, vol.28, pp.827-838, 2010.
, Gene Expression Profiling in Multiple Myeloma--Reporting of Entities, Risk, and Targets in Clinical Routine, Clinical Cancer Research, vol.17, issue.23, pp.7240-7247, 2011.
DOI : 10.1158/1078-0432.CCR-11-1628
, Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib, Blood, vol.109, issue.8, pp.3177-3188, 2007.
DOI : 10.1182/blood-2006-09-044974
, A gene-expression signature to predict survival in breast cancer across independent data sets, Oncogene, vol.365, issue.10, pp.1507-1516, 2007.
DOI : 10.1038/415530a
, Gene Expression-based Classification of Malignant Gliomas Correlates Better with Survival than Histological Classification, Cancer Research, vol.63, pp.1602-1607, 2003.
, A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer, New England Journal of Medicine, vol.351, issue.27, pp.2817-2826, 2004.
DOI : 10.1056/NEJMoa041588
, Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes, Journal of Clinical Oncology, vol.27, issue.8, pp.1160-1167, 2009.
DOI : 10.1200/JCO.2008.18.1370
, Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data, Molecular Cancer Therapeutics, vol.7, issue.5, pp.1013-1024, 2008.
DOI : 10.1158/1535-7163.MCT-07-0177
, Gene expression profiling in breast cancer: classification, prognostication, and prediction, The Lancet, vol.378, issue.9805, pp.1812-1823, 2011.
DOI : 10.1016/S0140-6736(11)61539-0
, A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1, Blood, vol.109, issue.6, pp.2276-2284, 2007.
DOI : 10.1182/blood-2006-07-038430
, Gene Expression-Based Molecular Diagnostic System for Malignant Gliomas Is Superior to Histological Diagnosis, Clinical Cancer Research, vol.13, issue.24, pp.7341-7356, 2007.
DOI : 10.1158/1078-0432.CCR-06-2789
, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proceedings of the National Academy of Sciences, pp.10869-10874, 2001.
DOI : 10.1073/pnas.191367098
, Gene-Expression Signatures in Breast Cancer, New England Journal of Medicine, vol.360, issue.8, pp.790-800, 2009.
DOI : 10.1056/NEJMra0801289
, The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor, Blood, vol.113, issue.19, pp.4614-4626, 2009.
DOI : 10.1182/blood-2008-07-170464
URL : https://hal.archives-ouvertes.fr/inserm-00367812
, Modeling Survival Data: Extending the Cox Model Gene expression profiling predicts clinical outcome of breast cancer, Nature, vol.415, pp.530-536, 2000.
, Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1, Cancer Cell, vol.17, issue.1, pp.98-110, 2010.
DOI : 10.1016/j.ccr.2009.12.020
, A Model-Based Background Adjustment for Oligonucleotide Expression Arrays, Journal of the American Statistical Association, vol.99, issue.468, pp.909-917, 2004.
DOI : 10.1198/016214504000000683